HealthEquity, Inc. (HQY)
- Previous Close
91.33 - Open
91.30 - Bid 90.23 x 100
- Ask 90.59 x 100
- Day's Range
89.51 - 92.21 - 52 Week Range
65.01 - 115.59 - Volume
594,182 - Avg. Volume
1,104,100 - Market Cap (intraday)
7.819B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
82.94 - EPS (TTM)
1.09 - Earnings Date Jun 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
110.93
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It provides health savings accounts; investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. The company also offers flexible spending accounts for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
www.healthequity.com3,105
Full Time Employees
January 31
Fiscal Year Ends
Sector
Industry
Recent News: HQY
View More
Performance Overview: HQY
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HQY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HQY
View MoreValuation Measures
Market Cap
7.82B
Enterprise Value
8.63B
Trailing P/E
82.94
Forward P/E
24.69
PEG Ratio (5yr expected)
0.99
Price/Sales (ttm)
6.69
Price/Book (mrq)
3.70
Enterprise Value/Revenue
7.19
Enterprise Value/EBITDA
25.45
Financial Highlights
Profitability and Income Statement
Profit Margin
8.06%
Return on Assets (ttm)
3.84%
Return on Equity (ttm)
4.66%
Revenue (ttm)
1.2B
Net Income Avi to Common (ttm)
96.7M
Diluted EPS (ttm)
1.09
Balance Sheet and Cash Flow
Total Cash (mrq)
295.95M
Total Debt/Equity (mrq)
52.42%
Levered Free Cash Flow (ttm)
-145.32M
Research Analysis: HQY
View MoreResearch Reports: HQY
View MoreRaising target price to $99.00
HEALTHEQUITY INC has an Investment Rating of BUY; a target price of $99.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetRaising target price to $95.00
HEALTHEQUITY INC has an Investment Rating of BUY; a target price of $95.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetWhat does Argus have to say about HQY?
HEALTHEQUITY INC has an Investment Rating of BUY; a target price of $91.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetRaising target price to $91.00
HEALTHEQUITY INC has an Investment Rating of BUY; a target price of $91.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target